Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hutchmed Share News (HCM)
HCM Share
Price
HCM Share
News
HCM Share
Chat2
HCM Share
Trades60
HCM
Live RNS
HCM Share
Charts
HCM Level 2
Console
HCM Live
Share Price
HCM Broker
Ratings
HCM Directors
Deals
HCM Financial
Diary
HCM
Fundamentals
HCM Short
Positions
HCM
Media
HCM Company
Research
HCM Company
Timeline
Hutchmed Information
Share Price Information for Hutchmed (HCM)
Share Price is delayed by 15 minutes
Get Live Data
170.50
5.75 (3.49%)
Bid:
168.00
Ask:
172.00
Spread:
4.00 (2.381%)
Market Cap:
£1.47b
Last checked at -
Last checked at 
Intraday Hutchmed Share Chart
Hutchmed News
4 Sep 2020
Hutchison Chi-Med begins latest trial of fruquintinib
(Sharecast News) - Hutchison China MediTech, trading as Chi-Med, said on Friday that it has initiated 'FRESCO-2' - a phase 3 registration study of 'fr...
3 Sep 2020
IN BRIEF: Hutchison China Initiates Phase II Trial Of HMPL-453
IN BRIEF: Hutchison China Initiates Phase II Trial Of HMPL-453
10 Aug 2020
IN BRIEF: Hutchison Chi-Med Plans Surufatnib Marketing Application
IN BRIEF: Hutchison Chi-Med Plans Surufatnib Marketing Application
30 Jul 2020
IN BRIEF: Hutchison China Interim Loss Widens Despite Revenue Growth
IN BRIEF: Hutchison China Interim Loss Widens Despite Revenue Growth
28 Jul 2020
IN BRIEF: Hutchison China Amends License Agreement With Eli Lilly
IN BRIEF: Hutchison China Amends License Agreement With Eli Lilly
24 Jul 2020
Hutchison Chi-Med begins phase 1 study of 'HMPL-306'
(Sharecast News) - Hutchison China MediTech, trading as Chi-Med, has initiated a phase 1 study of 'HMPL-306', it announced on Friday, in patients with...
24 Jul 2020
Chi-Med Trials Dual Inhibitor For Hematological Cancer
Chi-Med Trials Dual Inhibitor For Hematological Cancer
23 Jul 2020
UK Shareholder Meetings Calendar - Next 7 Days
UK Shareholder Meetings Calendar - Next 7 Days
Follow the stocks
